Q32 Bio Inc.
Company Stats
- Market Cap
- $246.2M
- as of Sep 30, 2026
- Shares Outstanding
- 29.8M
- Free Float
- 60.5%
Income Statement
- Revenue
- $53.7M
- Operating Income
- $16.9M
- Net Income
- $29.8M
- EBITDA
- $17.3M
- Revenue Growth, 3Y
- 155.9%
Cash Flow
- Free Cash Flow
- -$33.5M
- FCF Yield
- -13.6%
- Owner FCF Yield
- -15.8%
Balance Sheet
- Cash & Equivalents
- $48.3M
Returns & Capital
- SBC, 3Y Avg
- $3.7M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $53.7M | -$33.5M | -62.4% |
| FY2024 | $0 | -$67.8M | — |
| FY2023 | $1.2M | -$18.7M | -1616.1% |
| FY2022 | $3.2M | -$114.9M | -3583.1% |
| FY2021 | $34.0M | -$112.1M | -330.1% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 13, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges